• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Mosby's 2023 Nursing Drug Reference

Mosby's 2023 Nursing Drug Reference

9780323930727
238.08 zł
202.37 zł Save 35.71 zł Tax included
Lowest price within 30 days before promotion: 202.37 zł
Quantity
Product unavailable
Out of print

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description

Choose the drug handbook trusted by nurses for more than 35 years! Mosbys 2023 Nursing Drug Reference makes it easy to find the most vital information on the drugs you administer most frequently. More than 5,000 drugs are profiled - including 35 new entries for drugs recently approved by the FDA. And no other drug guide places a higher emphasis on patient safety, with Black Box Warnings for dangerous adverse reactions, Safety Alerts for situations requiring special attention, and a focus on both common and life-threatening side effects. From nursing pharmacology expert Linda Skidmore-Roth, this perennial bestseller proves there is a difference in drug guides.

Product Details
Mosby
91751
9780323930727
9780323930727

Data sheet

Publication date
2022
Issue number
36
Cover
paperback
Pages count
1504
Weight (g)
1110
  • INDIVIDUAL DRUG MONOGRAPHS
    APPENDIXES

    A. Selected New Drugs
    abametapir
    aducanumab-avwa
    afamelanotide
    anifrolumab-fnia
    asciminib
    atogepant
    avacopan
    avapritinib
    belumosudil
    belzutifan
    bempedoic acid
    brolucizumab-dbll
    difelikefalin
    dostarlimab-gxly
    eculizumab
    efavirenz/emtricitabine/tenofovir
    elapegademase-ivir
    elbasvir/grazoprevir
    elexacaftor/tezacaftor/ivacaftor and ivacaftor
    emtricitabine/rilpivirine/tenofovir alafenamide
    enalapril/hydrochlorothiazide
    ephedrine
    factor IX complex
    factor IX, human
    factor IX, recombinant
    finerenone
    fluocinolone
    fluocinonide
    lonapegsomatropin-tcgd
    loncastuximab tesirine-lpyl
    maribavir
    mobocertinib
    odevixibat
    ropeginterferon alfa-2b
    tisotumab vedotin-tftv
    vosoritide
    B. Ophthalmic, Nasal, Topical, and Otic Products
    C. Vaccines and Toxoids
    D. Recent FDA Drug Approvals
    INDEX
    EVOLVE WEBSITE

    . Additional Monographs
    . Drug Categories
Comments (0)